Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

38.18
Delayed Data
As of Oct 16
 +0.23 / +0.61%
Today’s Change
29.39
Today|||52-Week Range
45.87
+0.08%
Year-to-Date
Voyager Therapeutics (VYGR) Jumps: Stock Rises 7.8%
Oct 13 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Mylan Up, Teva Down on Copaxone News, Lawmakers Question Allerg...
Oct 06 / Zacks.com - Paid Partner Content
Mylan Receives CRL for Neulasta Biosimilar
Oct 11 / GuruFocus News - Paid Partner Content
Teva Down as Mylan's Copaxone 40 mg Generic Arrives Early
Oct 05 / Zacks.com - Paid Partner Content
Mylan Receives FDA's CRL for Neulasta Biosimilar
Oct 11 / GuruFocus News - Paid Partner Content
Company News For Oct 5, 2017
Oct 05 / Zacks.com - Paid Partner Content
Mylan Gets Complete Response Letter For Biosimilar Neulasta
Oct 11 / Zacks.com - Paid Partner Content
Mylan (MYL) Surges: Stock Moves 16.2% Higher
Oct 05 / Zacks.com - Paid Partner Content
Forget Teva (TEVA), Buy These 5 Drug Stocks Instead
Oct 09 / Zacks.com - Paid Partner Content
Teva Shares Plummet After Mylan's Copaxone Generic Gets FDA Approval
Oct 04 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close37.95
Today’s open38.03
Day’s range37.82 - 38.54
Volume6,493,299
Average volume (3 months)6,641,445
Market cap$20.4B
Dividend yield--
Data as of 3:59pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)-45.88%
Earnings growth (this year)-5.85%
Earnings growth (next 5 years)+3.21%
Revenue growth (last year)+17.44%
P/E ratio16.5
Price/Sales1.79
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.46-0.48%
PRGOPerrigo Company PLC-0.74-0.84%
JAZZJazz Pharmaceuticals...-0.88-0.62%
ALNYAlnylam Pharmaceutic...-1.11-0.91%
Data as of 3:59pm ET, 10/16/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.20
Annual revenue (last year)$11.1B
Annual profit (last year)$480.0M
Net profit margin4.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Heather M. Bresch
President &
Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts